153 related articles for article (PubMed ID: 28582274)
21. [The consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999].
Schwartz GF; Solin LJ; Olivotto IA; Ernster VL;
Bull Cancer; 2000 Jun; 87(6):499-506. PubMed ID: 10903791
[No Abstract] [Full Text] [Related]
22. Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer.
Smith BL; Bertagnolli M; Klein BB; Batter S; Chang M; Douville LM; Eberlein TJ
Ann Surg; 1992 Jul; 216(1):17-21. PubMed ID: 1321595
[TBL] [Abstract][Full Text] [Related]
23. Primary cutaneous large B-cell lymphoma of the leg relapsing as cutaneous intravascular large B-cell lymphoma.
Kamath NV; Gilliam AC; Nihal M; Spiro TP; Wood GS
Arch Dermatol; 2001 Dec; 137(12):1657-8. PubMed ID: 11735727
[No Abstract] [Full Text] [Related]
24. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer.
Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK
AJR Am J Roentgenol; 2003 Apr; 180(4):901-10. PubMed ID: 12646427
[TBL] [Abstract][Full Text] [Related]
25. [A practice guideline for diagnosis and treatment of ductal in situ carcinoma of the breast].
Delaloye JF; Wight E; Fink D; Otto R; Steiner R;
Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):64-7. PubMed ID: 16452823
[No Abstract] [Full Text] [Related]
26. E-cadherin immunohistochemistry in breast pathology: uses and pitfalls.
Canas-Marques R; Schnitt SJ
Histopathology; 2016 Jan; 68(1):57-69. PubMed ID: 26768029
[TBL] [Abstract][Full Text] [Related]
27. [Intravascular large b-cell lymphoma: case report].
Krivolapov IuA; Ivaniuk AV
Vopr Onkol; 2003; 49(6):743-7. PubMed ID: 14976920
[TBL] [Abstract][Full Text] [Related]
28. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
29. Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment.
Schwartz GF; Patchefsky AS; Finklestein SD; Sohn SH; Prestipino A; Feig SA; Singer JS
Arch Surg; 1989 Jan; 124(1):29-32. PubMed ID: 2535928
[TBL] [Abstract][Full Text] [Related]
30. Multicentric adenomyoepithelioma of the breast with atypia and associated ductal carcinoma in situ.
Han JS; Peng Y
Breast J; 2010; 16(5):547-9. PubMed ID: 20604795
[No Abstract] [Full Text] [Related]
31. Role of second-look ultrasound examinations for MR-detected lesions in patients with breast cancer.
Lee SH; Kim SM; Jang M; Yun BL; Kang E; Kim SW; Park SY; Ahn HS; Chang JH; Yoo Y; Song TK; Moon WK
Ultraschall Med; 2015 Apr; 36(2):140-8. PubMed ID: 25750138
[TBL] [Abstract][Full Text] [Related]
32. [Noninvasive breast carcinomas: anatomicopathological, diagnostic and therapeutic findings].
Calabrese L
Acta Biomed Ateneo Parmense; 1998; 69(3-4):113-21. PubMed ID: 10503071
[TBL] [Abstract][Full Text] [Related]
33. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
Pinder SE; Ellis IO
Breast Cancer Res; 2003; 5(5):254-7. PubMed ID: 12927035
[TBL] [Abstract][Full Text] [Related]
34. [Detection of microcalcifications by high-resolution B-mode sonography in patients with BI-RADS 4a lesions].
Stöblen F; Landt S; Köninger A; Hecktor J; Kimmig R; Kümmel S
Gynakol Geburtshilfliche Rundsch; 2009; 49(4):292-8. PubMed ID: 20530944
[TBL] [Abstract][Full Text] [Related]
35. Significance of HER2 protein examination in ductal carcinoma in situ.
Horimoto Y; Tokuda E; Arakawa A; Kosaka T; Saito M; Kasumi F
J Surg Res; 2011 May; 167(2):e205-10. PubMed ID: 20018297
[TBL] [Abstract][Full Text] [Related]
36. [In situ ductal carcinoma of the breast: a diagnostic challenge].
Fuchsjäger MH; Helbich TH
Wien Med Wochenschr Suppl; 2002; (113):69-73. PubMed ID: 12621847
[TBL] [Abstract][Full Text] [Related]
37. Breast MRI for cancer detection in a patient with diabetic mastopathy.
Gabriel HA; Feng C; Mendelson EB; Benjamin S
AJR Am J Roentgenol; 2004 Apr; 182(4):1081-3. PubMed ID: 15039192
[No Abstract] [Full Text] [Related]
38. [Consensus on pathological diagnosis of ductal carcinoma in situ of breast (2022 version)].
Members of Breast Cancer Expert Panel on Consensus on Pathological Diagnosis of Ductal Carcinoma In Situ of Breast (2022 version)
Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):812-818. PubMed ID: 36097895
[TBL] [Abstract][Full Text] [Related]
39. Intravascular B-cell lymphoma.
Hamilton R; Leach M; Jackson R
Eur J Haematol; 2012 Dec; 89(6):505-6. PubMed ID: 22906312
[No Abstract] [Full Text] [Related]
40. Synchronous carcinoma and lymphoma of the breast.
Anavekar NS; Rozen WM; Rowe K; Murphy C
Clin Breast Cancer; 2008 Jun; 8(3):281-4. PubMed ID: 18650160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
